D&D Pharmatech (XKRX:347850) Change In Inventory : ₩0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2024. Start your Free Trial

What is D&D Pharmatech Change In Inventory?

D&D Pharmatech's change in inventory for the quarter that ended in Mar. 2025 was ₩0 Mil. It means D&D Pharmatech's inventory stayed the same from Dec. 2024 to Mar. 2025 .

D&D Pharmatech's change in inventory for the fiscal year that ended in Dec. 2024 was ₩0 Mil. It means D&D Pharmatech's inventory stayed the same from Dec. 2023 to Dec. 2024 .

D&D Pharmatech's Total Inventories for the quarter that ended in Mar. 2025 was ₩0 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. D&D Pharmatech's Inventory-to-Revenue for the quarter that ended in Mar. 2025 was 0.00.

D&D Pharmatech Change In Inventory Historical Data

The historical data trend for D&D Pharmatech's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

D&D Pharmatech Change In Inventory Chart

D&D Pharmatech Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Inventory

Get a 7-Day Free Trial

D&D Pharmatech Quarterly Data
	Dec18	Dec19	Dec20	Dec21	Dec22	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Inventory	Get a 7-Day Free Trial								-	-	-	-	-

D&D Pharmatech Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩0 Mil.

D&D Pharmatech (XKRX:347850) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

D&D Pharmatech's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	0	/	0	*	365 / 4
	=	N/A

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

D&D Pharmatech's Inventory Turnover for the quarter that ended in Mar. 2025 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0	/	0
	=	N/A

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

D&D Pharmatech's Inventory to Revenue for the quarter that ended in Mar. 2025 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0	/	1413.462
	=	0.00

D&D Pharmatech Change In Inventory Related Terms

Thank you for viewing the detailed overview of D&D Pharmatech's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

D&D Pharmatech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » D&D Pharmatech Inc (XKRX:347850) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

4th floor, 24, Pangyo-ro 255beon-gil, Bundang-gu, Gyeonggi-do, Sampyeong-dong, I&C Building, Seongnam-si, KOR

Website

http://www.ddpharmatech.com

D&D Pharmatech Inc is a company that comprises of experts in the field of bio-new drug research and development and technology commercialization, including basic scientists in the pharmaceutical biofield, manufacturing quality control (CMC) experts, and clinical development and technology transfer experts. Other business areas include the development of positron emission tomography (PET) imaging biomarkers conducted by Precision Molecular Inc. a 100% subsidiary, and single-cell sequencing related to degenerative brain diseases conducted by Valted Seq, Inc. The company utilizes drug delivery technologies such as PEGylation technology, which helps extend the administration interval using PEG and various chemicals, and platform technology that converts injectable drugs into oral preparations.

D&D Pharmatech Headlines

No Headlines